Drugs for 'protein clouds': targeting intrinsically disordered transcription factors

被引:133
作者
Dunker, A. Keith [1 ,2 ]
Uversky, Vladimir N. [1 ,2 ,3 ,4 ]
机构
[1] Indiana Univ, Sch Med, Inst Intrinsically Disordered Prot Res, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[3] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA
[4] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
SMALL-MOLECULE ANTAGONISTS; UNSTRUCTURED PROTEINS; P53-MDM2; INTERACTION; BINDING DOMAIN; RNA HELICASE; P53; INHIBITORS; RECOGNITION; ACTIVATION; REGIONS;
D O I
10.1016/j.coph.2010.09.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Transcription factors (TFs) are very attractive but difficult drug targets The difficulties come from several directions including the binding promiscuity of TFs and the intrinsically disordered nature of their binding sites, which often resemble 'protein clouds For a long time the targeting of proteins without defined structures was considered infeasible Data have now emerged showing that selective blocking of specific interactions of intrinsically disordered TFs with their protein binding partners is possible Initial hits have been optimized to increase their specificity and affinity Several strategies have been elaborated for elucidating the mechanisms of blocking of intrinsic disorder-based protein protein interactions However, challenges remain in the field of drug development for 'protein clouds', such development is still in its earliest stage
引用
收藏
页码:782 / 788
页数:7
相关论文
共 56 条
[1]  
ANDERSON CW, 2004, HDB CELL SIGNALING, V237, P247
[2]   Structure of a Sir2 enzyme bound to an acetylated p53 peptide [J].
Avalos, JL ;
Celic, I ;
Muhammad, S ;
Cosgrove, MS ;
Boeke, JD ;
Wolberger, C .
MOLECULAR CELL, 2002, 10 (03) :523-535
[3]   Activation and activities of the p53 tumour suppressor protein [J].
Bálint, É ;
Vousden, KH .
BRITISH JOURNAL OF CANCER, 2001, 85 (12) :1813-1823
[4]  
Chène P, 2004, MOL CANCER RES, V2, P20
[5]   Rational drug design via intrinsically disordered protein [J].
Cheng, Yugong ;
LeGall, Tanguy ;
Oldfield, Christopher J. ;
Mueller, James P. ;
Van, Ya-Yue J. ;
Romero, Pedro ;
Cortese, Marc S. ;
Uversky, Vladimir N. ;
Dunker, A. Keith .
TRENDS IN BIOTECHNOLOGY, 2006, 24 (10) :435-442
[6]   Calculation of ensembles of structures representing the unfolded state of an SH3 domain [J].
Choy, WY ;
Forman-Kay, JD .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 308 (05) :1011-1032
[7]  
Dang CV, 1999, MOL CELL BIOL, V19, P1
[8]   GENE FUSION WITH AN ETS DNA-BINDING DOMAIN CAUSED BY CHROMOSOME-TRANSLOCATION IN HUMAN TUMORS [J].
DELATTRE, O ;
ZUCMAN, J ;
PLOUGASTEL, B ;
DESMAZE, C ;
MELOT, T ;
PETER, M ;
KOVAR, H ;
JOUBERT, I ;
DEJONG, P ;
ROULEAU, G ;
AURIAS, A ;
THOMAS, G .
NATURE, 1992, 359 (6391) :162-165
[9]   ANCHOR: web server for predicting protein binding regions in disordered proteins [J].
Dosztanyi, Zsuzsanna ;
Meszaros, Balint ;
Simon, Istvan .
BIOINFORMATICS, 2009, 25 (20) :2745-2746
[10]   Intrinsically disordered protein [J].
Dunker, AK ;
Lawson, JD ;
Brown, CJ ;
Williams, RM ;
Romero, P ;
Oh, JS ;
Oldfield, CJ ;
Campen, AM ;
Ratliff, CR ;
Hipps, KW ;
Ausio, J ;
Nissen, MS ;
Reeves, R ;
Kang, CH ;
Kissinger, CR ;
Bailey, RW ;
Griswold, MD ;
Chiu, M ;
Garner, EC ;
Obradovic, Z .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2001, 19 (01) :26-59